Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial - Kapp-Schwoerer, Silke; Weber, Daniela; Corbacioglu, Andrea; Gaidzik, Verena I.; Paschka, Peter; Krönke, Jan; Theis, Frauke; Rücker, Frank G.; Teleanu, Maria-Veronica; Panina, Ekaterina; Jahn, Nikolaus; Herzig, Julia; et al. (Blood, 2020)
Gesehen am 11.02.2021